Drug Reference

Tivozanib

Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

← All medicines · Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

Fact box

Therapeutic class
Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
Action class
Kinase Inhibitor
Mechanism
Tyrosine Kinase Inhibitors
Habit forming
No

Brand names

Fotivda

Available as

0.89 MG · Oral Capsule1.34 MG · Oral Capsule

No structured FDA label was available. Use the authoritative links below.

Current FDA labels (DailyMed)

4 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.